Human infection with a novel avian influenza virus, A(H7N9), China - 2nd update, 8 May 2013
This second update to ECDC's initial risk assessment concludes that the risk of the disease spreading to Europe via humans or through poultry is still low at this time.
Rapid risk assessment: Severe respiratory disease associated with a novel influenza A virus, A(H7N9) China
On 31 March 2013, the Chinese authorities announced the identification of a novel influenza A virus, A(H7N9), in three seriously ill people from two provinces presenting with respiratory infections. So far, no epidemiological link has been identified between those three patients. When testing for the influenza virus, the Chinese Center for Disease Control and Prevention identified genes from both A(H7N9) and A(H9N2) viruses, thus indicating a novel reassortant avian influenza A virus. In its initial assessment of the situation, the ECDC rapid risk assessment concludes that the risk of the spread of the virus in Europe can be considered low at this stage.
Rapid risk assessment: Human infections with avian influenza A viruses, China
This Rapid Risk Assessment summarises the latest information about human infections with avian influenza A viruses in China.
Respiratory tract infections - Annual epidemiological report for 2012-13
The Annual Epidemiological Report 2014 gives an overview of the epidemiology of communicable diseases of public health significance in Europe, drawn from surveillance information on the 52 communicable diseases and health issues for which surveillance is mandatory in the European Union and European Economic Area countries. The respiratory tract infections chapter from the upcoming ECDC Annual Epidemiological Report 2014 is now available as a separate report and provides a snapshot of the epidemiological situation in Europe across a number of diseases.
Rapid Risk Assessment: Human infection with influenza virus A(H7N9) virus - 4th update, 3 February 2015
This fourth update of the risk assessment on human infection with avian influenza A(H7N9) virus, summarises the epidemiological and virological information on the disease in China and Canada, and assesses the risk to public health in the EU/EEA and to EU/EEA citizens.
Rapid Risk Assessment: Human infection by low pathogenic avian influenza A(H7) viruses, 13 February 2015
This rapid risk assessment summarises the epidemiological and virological information about human infections with low pathogenic avian influenza A(H7N7) viruses and assesses the risk to public health in the EU/EEA, in response to this outbreak.
Human infection with avian influenza A(H7N9) virus - 5th update, 27 January 2017
Fifth update of the risk assessment on human infection with avian influenza A(H7N9) virus, summarising the epidemiological and virological information on the disease in China and Canada, and assessing the risk to public health in the EU/EEA.
Genetic evolution of influenza A(H7N9) virus in China - implications for public health. Sixth update, 9 March 2017
This rapid risk assessment builds on the fifth update of the ECDC rapid risk assessments on avian influenza published on 27 January 2017  and on the recent public health development dated 24 February 2017.
4th Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting 2014
WHO/Europe has been holding annual influenza surveillance meetings jointly with the European Centre for Disease Prevention and Control (ECDC) since 2011. This meeting brought together epidemiologists and virologists – the national influenza surveillance focal points – from 50 Member States to discuss national, regional and global surveillance related to seasonal influenza and novel influenza viruses, such as avian influenza A(H7N9).
Epidemiological update: A(H7N9) influenza virus, China, 19 December 2013
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) avian influenza virus in patients in eastern China.